Identification of phenotypic markers of B cells from patients with Chagas disease

Parasite Immunology

Volumn 35, Issue 7-8, 2013, Pages 214-223

  Fares, R C G ^a   Correa Oliveira, R ^a,b   de Araujo F F ^a   Keesen, T S L ^c   Chaves, A T ^a   Fiuza, J A ^a   Ferreira, K S ^d   Rocha, M O C ^d   Gomes, J A S ^d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b National Institute of Science and Technology in Tropical Diseases INCT DT   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

B lymphocytes; Chagas disease; IL 10; Immunoregulation; Phenotypic markers

Indexed keywords

B7 ANTIGEN; CASPASE 3; CD19 ANTIGEN; CD23 ANTIGEN; CD24 ANTIGEN; CD5 ANTIGEN; CD86 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; GRANZYME B; HLA DR ANTIGEN; INTERLEUKIN 10; LEUKOSIALIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CHAGAS DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRYPANOSOMA CRUZI;

B LYMPHOCYTES; CHAGAS DISEASE; IL-10; IMMUNOREGULATION; PHENOTYPIC MARKERS;

ADULT; ANTIGENS, CD; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CASPASE 3; CHAGAS DISEASE; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA; TRYPANOSOMA CRUZI;

EID: 84879835919     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12038     Document Type: Article

References (57)

1. Chagas C. Nova espécie mórbida do homem produzida por um trypanosoma (Trypanosoma cruzi). Nota prévia Brás Med 1909; 23: 161.
2. Coura JR & Dias JCP. Epidemiology, control and surveillance of Chagas disease - 100 years after its discovery. Mem Inst Oswaldo Cruz 2009; 104(Suppl. I): 31-40.
3. o340, Junho 2010. Disponível em: http://www.who.int.
4. Dias JCP. The indeterminate form of human chronic Chagas disease: a clinical epidemiological review. Rev Soc Bras Med Trop 1989; 22: 147-156.
5. Macedo VO. Forma indeterminada da doença de Chagas. Rio de janeiro, FIOCRUZ, 1997.
6. Moncayo A & Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 2009; 104(Suppl I): 17-30.
7. Coura JR & Borges-Pereira J. Chagas disease: 100 years after its discovery. A systemic review. Acta Trop 2010; 115: 5-13.
8. Rassi A Jr, Rassi A, Little WC, et al. Development and validation of a risk score for predicting mortality in Chagas heart disease. N Engl J Med 2006; 355: 799-808.
9. Rocha MO, Teixeira MM & Ribeiro AL. An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 2007; 5: 727-743.
10. Tanowitz HB, Machado FS, Jelicks LA, et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis 2009; 51: 524-539.
11. high regulatory T cells in morbidity in Chagas disease. Front Biosci 2007; 12: 2797-2806.
12. Bahia-Oliveira LM, Gomes JA, Cançado JR, et al. Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago. J Infect Dis 2000; 182: 634-638.
13. Sathler-Avelar R, Vitelli-Avelar DM, Teixeira-Carvalho A & Martins-Filho AO. Innate immunity and regulatory T-cells in human Chagas disease: what must be understood? Mem Inst Oswaldo Cruz 2009; 104(suppl I): 246-251.
14. + T cells, the key to control Chagas disease morbidity. Clin Exp Immunol 2006; 145: 81-92.
15. Cordeiro FD, Martins-Filho OA, Da Costa Rocha MO, Adad SJ, Corrêa-Oliveira R, Romanha AJ. Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas disease. Clin Diagn Lab Immunol 2001; 8: 112-118.
16. + B cells or activated T cells of chagasic patients, respectively. Scand J Immunol 2000; 51: 91-97.
17. Minoprio PM, Eisen H, Forni L, D'imperio Lima MR, Joskowicz M, Coutinho A. Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses. Scand J Immunol 1986; 24: 661-668.
18. Pellegrini A, Carrera-Silva EA, Arocena A, Cano RC, Aoki MP & Gea S. Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity. Med Microbiol Immunol 2011; 200: 209-218.
19. Piedras J, Gutierrez S, Reyes-López PA, Reyes K, López-Karpovitch X & Monteón V. Circulating lymphocyte subpopulations and activated T and B cells in patients with chagasic and non-chagasic myocardiopathy. Cytometry 1997; 15: 30.
20. Bryan MA, Guyach SE & Norris KA. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice. PLoS Negl Trop Dis 2010; 6(4): e733.
21. Bermejo DA, Amezcua-Vesely MC, Montes CL, et al. BAFF mediates splenic B cell response and antibody production in experimental Chagas disease. PLoS Negl Trop Dis 2010; 4(4): e679.
22. + T cell activation in mice. Proc Natl Acad Sci USA 2007; 104: 20878-20883.
23. + T cells to protein antigens in vivo. J Immunol 1995; 155: 3734-3741.
24. Harris DP, Haynes L, Sayles PC, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000; 1: 475-482.
25. Linton PJ, Bautista B, Biederman E, et al. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med 2003; 197: 875-883.
26. Watanabe R, Fujimoto M, Ishiura N, et al. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol 2007; 171: 560-570.
27. Barbeiro DF, Barbeiro HV, Faintuch J, et al. B-1 cells temper endotoxemic inflammatory responses. Immunobiology 2011; 216: 302-308.
28. Lund FE. Cytokine-producing B lymphocytes - Key regulators of immunity. Curr Opin Immunol 2008; 20: 332-338.
29. Tung JW, Mrazek MD, Yang Y, Herzenberg Leonard A, Herzenberg Leonore A. Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse. Proc Natl Acad Sci USA 2006; 103: 6293-6298.
30. Tung JW & Herzenberg Leonore A. Unraveling B-1 progenitors. Curr Opin Immunol 2007; 19: 150-155.
31. Mizoguchi A & Bhan AK. A case for regulatory B cells. J Immunol 2006; 176: 705-710.
32. Bouaziz JD, Yanaba K & Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008; 224: 201-214.
33. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T & Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009; 182: 7459-7472.
34. + regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity. Immunobiology 2012; 217: 768-777.
35. Sathler-Avelar R, Lemos EM, Reis DD, et al. Phenotypic features of peripheral blood leucocytes during early stages of human infection with Trypanosoma cruzi. Scand J Immunol 2003; 58: 655-663.
36. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS & Bhan K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16: 219-230.
37. Sonoda KH & Stein-Streilein J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J Immunol 2002; 32: 848-857.
38. Dalwadi H, Wei B, Schrage M, et al. B cell development requirement for the G alpha i2 gene. J Immunol 2003; 170: 1707-1715.
39. Brummel R & Lenert P. Activation of marginal zone B cells from lúpus mice with type A(D) CpG-oligodeoxynucleotides. J Immunol 2005; 174: 2429-2434.
40. Wei DG, Lee H, Park SH, et al. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J Exp Med 2005; 202: 239-248.
41. Moir S & Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009; 9: 235-245.
42. Weiss GE, Clark EH, Li S, et al. A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali. PLoS ONE 2011; 14(6): e15983.
43. Santos Lda S, Torres RM, Machado-de-Assis GF, et al. In-house ELISA method to analyze anti-Trypanosoma cruzi IgG reactivity for differential diagnosis and evaluation of Chagas disease morbidity. Rev Soc Bras Med Trop 2012; 45: 35-44.
44. + T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol 2007; 178: 3447-3456.
45. - cells from chagasic patients: distinct repertoire and cytokine expression. Clin Exp Immunol 2004; 137: 129-138.
46. Trapani JA. Granzymes: a family of lymphocyte granule serine proteases. Genome Biol 2001; 2: 3014.
47. + CTLs ex vivo. J Immunol 2002; 168: 5954-5958.
48. +, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004; 173: 1834-1841.
49. Krammer PH, Arnold R & Lavrik IN. Life and death in peripheral T cells. Nat Rev Immunol 2007; 7: 532-542.
50. Mauri C & Ehrenstein MR. The 'short' history of regulatory B cells. Trends Immunol 2007; 29: 34-40.
51. (+) Cytotoxic Lymphocytes and Apoptosis Markers Induced by Trypanossoma cruzi Infection. Scand J Immunol 2012; 76: 311-319.
52. Acosta Rodriguez EV, Zuniga EI, Montes CL, et al. Trypanosoma cruzi infection beats the B-cell compartment favouring parasite establishment: can we strike first? Scand J Immunol 2007; 66: 137-142.
53. Gotot J, Gottschalk C, Leopold S, et al. Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo. Proc Natl Acad Sci USA 2012; 109: 10468-10473.
54. Duddy ME, Alter A & Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation? J Immunol 2004; 172: 3422-3427.
55. Majlessi L, Lo-Man R, Leclerc C. Regulatory B and T cells in infection. Microbes Infect 2008; 10: 1030-1035.
56. Lemoine S, Morva A, Youinou P & Jamin C. Regulatory B cells in autoimmunie disease. Ann N Y Acad Sci. 2009; 1173: 260-267.
57. (+) T cells. Mucosal Immunol. 2012; 5: 691-701.